UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials

Journal of clinical oncology, 2015-10, Vol.33 (29), p.3243-3250

2015

Link zum Volltext

Verfügbarkeit prüfen

The changing therapeutic landscape of head and neck cancer

Nature reviews. Clinical oncology, 2019-11, Vol.16 (11), p.669-683

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

The lancet oncology, 2016-07, Vol.17 (7), p.956-965

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for head and neck cancer: Recent advances and future directions

Oral oncology, 2019-12, Vol.99, p.104460-104460, Article 104460

2019

Link zum Volltext

Verfügbarkeit prüfen

STING enhances cell death through regulation of reactive oxygen species and DNA damage

Nature communications, 2021-04, Vol.12 (1), p.2327-2327, Article 2327

2021

Link zum Volltext

Verfügbarkeit prüfen

Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1304-1311

2020

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of extranodal extension in human papillomavirus‐associated oropharyngeal squamous cell carcinoma

Cancer, 2017-07, Vol.123 (14), p.2762-2772

2017

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks

Scientific reports, 2018-09, Vol.8 (1), p.14036-11, Article 14036

2018

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

The lancet oncology, 2016-06, Vol.17 (6), p.717-726

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

Journal of clinical oncology, 2022-01, Vol.40 (2), p.138-149

2022

Link zum Volltext

Verfügbarkeit prüfen

TRAF3/CYLD mutations identify a distinct subset of human papillomavirus‐associated head and neck squamous cell carcinoma

Cancer, 2017-05, Vol.123 (10), p.1778-1790

2017

Link zum Volltext

Verfügbarkeit prüfen

Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition

The lancet oncology, 2013-07, Vol.14 (8), p.e302-e309

2013

Link zum Volltext

Verfügbarkeit prüfen

High Dose Cisplatin: Still the One?

International journal of radiation oncology, biology, physics, 2020-07, Vol.107 (4), p.615-616

2020

Link zum Volltext

Verfügbarkeit prüfen

The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss

JNCI : Journal of the National Cancer Institute, 2022-10, Vol.114 (10), p.1333-1337

2022

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database

Head & neck, 2018-07, Vol.40 (7), p.1343-1355

2018

Link zum Volltext

Verfügbarkeit prüfen

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.184-184, Article 184

2019

Link zum Volltext

Verfügbarkeit prüfen

First-Line Nivolumab Plus Ipilimumab in Recurrent/Metastatic Head and Neck Cancer-What Happened?

Journal of clinical oncology, 2023-04, Vol.41 (12), p.2134-2137

Burtness, Barbara

2023

Link zum Volltext

Verfügbarkeit prüfen

HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes

The Laryngoscope, 2019-03, Vol.129 (3), p.684-691

2019

Link zum Volltext

Verfügbarkeit prüfen

NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis

Nature communications, 2017-11, Vol.8 (1), p.1772-10, Article 1772

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

Journal of clinical oncology, 2013-04, Vol.31 (11), p.1405-1414

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer

Modern pathology, 2021-03, Vol.34 (3), p.532-541

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck

Cancers, 2017-08, Vol.9 (9), p.113

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8646-8654

2005

Link zum Volltext

Verfügbarkeit prüfen

Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma

Oral oncology, 2016-11, Vol.62, p.147-148

2016

Link zum Volltext

Verfügbarkeit prüfen

Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival – A National study

Oral oncology, 2022-02, Vol.125, p.105694-105694, Article 105694

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 418

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(359)
Mit Volltextzugriff
(363)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(418)
Japanisch
(48)

Erscheinungsjahr

n.n

Thema

Science & Technology
(240)
Life Sciences & Biomedicine
(233)
Oncology
(214)
Humans
(195)
Female
(103)
Male
(89)
Middle Aged
(83)
Head And Neck Cancer
(76)
Aged
(71)
Adult
(60)
Tumors
(52)
Head & Neck Cancer
(44)
Human Papillomavirus
(44)
Cancer
(42)
Prognosis
(42)
Chemotherapy
(41)
Squamous Cell Carcinoma
(40)
Head And Neck Neoplasms - Drug Therapy
(36)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Aged, 80 And Over
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials

The changing therapeutic landscape of head and neck cancer

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Immunotherapy for head and neck cancer: Recent advances and future directions

STING enhances cell death through regulation of reactive oxygen species and DNA damage

Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma

The prognostic value of extranodal extension in human papillomavirus‐associated oropharyngeal squamous cell carcinoma

Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

TRAF3/CYLD mutations identify a distinct subset of human papillomavirus‐associated head and neck squamous cell carcinoma

Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition

High Dose Cisplatin: Still the One?

The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss

Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

First-Line Nivolumab Plus Ipilimumab in Recurrent/Metastatic Head and Neck Cancer-What Happened?

HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes

NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer

Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck

Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study

Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma

Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival – A National study

Suchergebnisse filtern